This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Miles A. Miller: Innovator in Pharmaceutical Chemistry
Introduction
Miles A. Miller is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of prodrugs. His innovative work has the potential to enhance drug delivery systems and improve treatment outcomes for various diseases.
Latest Patents
Miles A. Miller holds a patent for "Prodrugs with a tridentate self-immolative linker." This patent describes a compound that can be encapsulated in a particle and administered to a subject. The drug payload is released through an uncaging reaction, providing a novel approach to drug delivery. The methods outlined in this patent aim to treat diseases that are advantageously treatable by the drug involved.
Career Highlights
Miller is associated with The General Hospital Corporation, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that can significantly impact patient care and treatment methodologies.
Collaborations
Miles A. Miller has collaborated with esteemed colleagues such as Ralph Weissleder and Hannes Mikula. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Miles A. Miller's contributions to pharmaceutical chemistry through his innovative patent work exemplify the importance of research and development in improving healthcare solutions. His ongoing efforts at The General Hospital Corporation continue to pave the way for advancements in drug delivery systems.